[Annual Report] Central and Eastern…
Fierce Biotech: Chinese Vaccine Developer…
Clinical first-in-human study evaluating the safety and tolerability of an investigational cancer immunotherapy in patients with advanced melanoma.
OCT Clinical Data Management team managed a wide range of CRFs and Database development despite the complexity of the study design and treatment schema. Download the full case study to find out how we have been delivering the results.